Progyny signals $200M share repurchase and targets $1.278B 2025 revenue while expanding supplemental fertility plans
Source: SeekingAlpha
2025-11-06 19:26:57 ET
More on Progyny
- Progyny, Inc. (PGNY) Q3 2025 Earnings Call Transcript
- Progyny's Strong Fundamentals And Global Growth: Why I Choose To Buy
- Progyny Non-GAAP EPS of $0.45 beats by $0.06, revenue of $313.3M beats by $14.07M
- Progyny Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Progyny
Read the full article on Seeking Alpha
For further details see:
Progyny signals $200M share repurchase and targets $1.278B 2025 revenue while expanding supplemental fertility plans
Progyny Inc.
NASDAQ: PGNY
PGNY Trading
-2.74% G/L:
$17.01 Last:
437,902 Volume:
$17.50 Open:
PGNY Latest News
PGNY Stock Data
$1,856,999,027
78,107,759
1.06%
116
N/A
Healthcare Providers & Services
Healthcare
US
New York
